Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
GO drug may improve outcome of bone marrow transplantation for select pediatric leukemia patients

GO drug may improve outcome of bone marrow transplantation for select pediatric leukemia patients

FDA approves ibrutinib for treatment of mantle cell lymphoma

FDA approves ibrutinib for treatment of mantle cell lymphoma

Acquired resistance to cancer therapies: an interview with Dr Rajendra Kumari, Chief Scientific Officer at PRECOS

Acquired resistance to cancer therapies: an interview with Dr Rajendra Kumari, Chief Scientific Officer at PRECOS

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

Life-saving bone marrow transplants may also cure peanut allergies

Life-saving bone marrow transplants may also cure peanut allergies

ImmunGene secures $9 million in Series A financing from Ally Bridge Group

ImmunGene secures $9 million in Series A financing from Ally Bridge Group

Majerus to donate $2M for new Primary Children's and Families' Cancer Research Center at HCI

Majerus to donate $2M for new Primary Children's and Families' Cancer Research Center at HCI

Viewpoints: Obama's 'sin of omission;' Dems' panic grows over health law woes; men should pay for maternity care

Viewpoints: Obama's 'sin of omission;' Dems' panic grows over health law woes; men should pay for maternity care

Scientists investigate combined action of two different compounds against CML

Scientists investigate combined action of two different compounds against CML

Stanford researchers receive $1.37M grant to study on immune systems of pediatric cancer patients

Stanford researchers receive $1.37M grant to study on immune systems of pediatric cancer patients

Biothera announces top-line results from Phase 2b clinical trial in non-small cell lung cancer

Biothera announces top-line results from Phase 2b clinical trial in non-small cell lung cancer

BioLineRx obtains regulatory approval to initiate BL-7010 Phase 1/2 trial for celiac disease

BioLineRx obtains regulatory approval to initiate BL-7010 Phase 1/2 trial for celiac disease

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

Early stem cell transplants does not improve overall survival in non-Hodgkin's lymphoma patients

Early stem cell transplants does not improve overall survival in non-Hodgkin's lymphoma patients

Janssen submits Marketing Authorization Application for Ibrutinib

Janssen submits Marketing Authorization Application for Ibrutinib

Cytrx announces Q3 2013 financial results, provides clinical update

Cytrx announces Q3 2013 financial results, provides clinical update

Study evaluates sexual well-being in SCT survivors using sexual function assessment tools

Study evaluates sexual well-being in SCT survivors using sexual function assessment tools

Leukemia drug reverses symptoms of colitis in lab tests

Leukemia drug reverses symptoms of colitis in lab tests

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Study uncovers new genetic pathways that could revolutionise acute dendritic leukaemia treatment

Study uncovers new genetic pathways that could revolutionise acute dendritic leukaemia treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.